COPPSERS
DMAAR

Commonwealth of Pennsylvania Public School Employees Retirement System’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-117,544
Closed -$7.05K – 1891
2026
Q1 		$7.05K Buy
+117,544
New +$12.4K ﹤0.01% 1754

Other funds holding DMAAR

WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM

Commonwealth of Pennsylvania Public School Employees Retirement System's DMAAR Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Drugs Made In America Acquisition Corp Rights (DMAAR) in Q2 2026, closing a stake of 117,544 shares — an estimated $7.05K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in DMAAR in Q1 2026 and held it in 1 quarter. The position peaked at $7.05K in Q1 2026. 4 funds tracked by Wall St. Rank hold DMAAR as of Q2 2026.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Drugs Made In America Acquisition Corp Rights position as of Q2 2026 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 117,544 Drugs Made In America Acquisition Corp Rights shares in Q2 2026, an estimated $7.05K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Drugs Made In America Acquisition Corp Rights in Q1 2026 and held it in 1 quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Drugs Made In America Acquisition Corp Rights position peaked at $7.05K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.